Article Details
Retrieved on: 2022-09-23 07:41:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Nirmatrelvir, a novel main protease (Mpro) inhibitor originating in Pfizer's laboratories, is specifically designed to block the activity of the SARS- ...
Article found on: www.precisionvaccinations.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here